GSK Raises Product Prices in US And Europe As Costs Rise

GSK revealed price increases in the US, Europe and China as it posted Q3 sales up high single-digits, with gains in key categories such as pain relief and vitamins, minerals and supplements.

arrows pointing upwards
• Source: Alamy

GlaxoSmithKline Consumer Healthcare is rolling out product price increases around the globe in a response to further pressure from cost inflation.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business